![]() | |
Names | |
---|---|
IUPAC name
5-[(3S,5R,10S,11S,13R,14S,17R)-3,11,14-trihydroxy-10,13-dimethyl-12-oxo-2,3,4,5,6,7,8,9,11,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one
| |
Other names
Arenobufagin
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C24H32O6 | |
Molar mass | 416.514 g·mol−1 |
Appearance | liquid |
Density | 1.4±0.1 g/cm3 |
Boiling point | 637.2±55.0 °C at 760 mmHg |
Vapor pressure | 0.0±4.3 mmHg at 25 °C |
Refractive index (nD)
|
1.622 |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Cardiotoxic |
GHS labelling: | |
![]() | |
Danger | |
Flash point | 219.3±25.0 °C |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Arenobufagin is a cardiotoxic bufanolide steroid secreted by the Argentine toad Bufo arenarum.[1] It has effects similar to digitalis, blocking the Na+/K+ pump in heart tissue.[2]